AI assistant
BLUGLASS LIMITED — Interim / Quarterly Report 2018
Feb 12, 2018
64532_rns_2018-02-12_8d66fb15-4a58-440f-9a2d-1c5451ef27e8.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
==> picture [231 x 49] intentionally omitted <==
INTERIM FINANCIAL REPORT FOR THE HALF YEAR ENDED 31 DECEMBER 2017
==> picture [595 x 369] intentionally omitted <==
BLUGLASS LIMITED and CONTROLLED ENTITIES ABN 20 116 825 793
BluGlass Limited
Page 1 of 17
Half Yearly Results 31 December 2009
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
| CONTENTS | Page |
|---|---|
| Directors’ Report | 3 |
| Auditor’s Independence Declaration | 8 |
| Consolidated Statement of Profit or Loss and Other Comprehensive Income | 9 |
| Consolidated Statement of Financial Position | 10 |
| Consolidated Statement of Changes in Equity | 11 |
| Consolidated Statement of Cash Flows | 12 |
| Notes to the Financial Statements | 13 |
| Directors’ Declaration | 15 |
| Independent Auditor’s Review Report | 16 |
BluGlass Limited
Page 2 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
DIRECTORS’ REPORT
Your directors present their report on the company and its controlled entities for the half-year ended 31 December 2017.
Directors
The names of directors in office at any time during or since the end of the half year are:
Mr Greg Cornelsen
Mr Chandra Kantamneni
Dr William Johnson
Mr Giles Bourne
Mr Vivek Rao
Mr James Walker (appointed 25 July 2017)
Principal Activities
The principal activity of the consolidated entity during the half year was the further development and commercialisation of novel technology for the manufacture of epitaxially grown gallium nitride at low temperature. BluGlass is also engaged in research activities in developing other high efficiency nitride devices.
All research and development activites are conducted in BluGlass Limited. There were no other significant changes in the nature of the consolidated entity’s principal activities during the half year.
Operating Results
Revenue has increased by $31,331 up 2.5% to $1,291,910 due to the following factor:
- Foundry services income up 31.7% to $268,149 (2016: $203,468).
Gross expenditure has decreased by $71,562, down 2.2% due to the following factors:
-
Consulting fees down 42.8% to $103,251 (2016: $180,367).
-
Patent and trademark expense down 48.2% to $75,473 (2016: $145,688)
-
Depreciation expense down 59.8% to $101,918 (2016: $253,319)
The consolidated loss for the period amounted to $1,959,535 down 5% (2016: $2,062,428).
The company’s net assets as at 31 December 2017 was $16,965,785 (30 June 2017: $18,701,811).
The Statement of Financial Position does not include a value for the increasing number of patents granted during the period since listing on the ASX in 2006 as all research and development costs are expensed as incurred and not capitalised.
Dividends Paid or Recommended
No dividends were paid or declared during the period.
BluGlass Limited
Page 3 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
REVIEW OF OPERATIONS
During the December 2017 Half Year BluGlass continued to advance the development and commercialisation of its proprietary RPCVD technology, successfully scaling the technology to larger wafer deposition with the commissioning of the upgraded BLG-300 deposition platform. The Company published its best material performance data to date, filed new patent applications, and continued to advance its strategic projects with our US and UK based partners.
==> picture [278 x 415] intentionally omitted <==
Operational Update
Key achievements during the half year include: • In July 2017, technology commercialisation expert James Walker joined the BluGlass Board of Directors as a NonExecutive Director. James brings a strong track record in successfully delivering cutting-edge technology into emerging markets.
• In August 2017, BluGlass successfully delivered a major hardware upgrade project to improve the uniformity and demonstrate the scalability of the RPCVD technology with the successful installation and commissioning of the upgraded BLG-300, the larger of the two RPCVD platforms.
-
In September 2017, BluGlass
-
announced that it had entered into a unique partnership with Griffith University and the Innovative Manufacturing Cooperative Research Centre (IMCRC). This two-year, $600,000 cofunded research project combines two Australian enabling technologies - BluGlass’ RPCVD technology and Griffith University’s Atomically Smooth SiC on large Si (SiC on Si) wafers to develop the next-generation GaN transistors, called High Performance Normally OFF GaN High Electron Mobility Transistors (HEMT)s.
• Also in September 2017, the upgraded BLG-300 demonstrated good thickness uniformity over 2, 4 and 6-inch wafers suitable for BluGlass’ commercial demonstrations.
At the time of this announcement, the improved chamber was already producing LED efficiency on par with previous best RPCVD results and with significantly improved performance uniformity. All of this is substantial progress for the company towards demonstrating that the scaling design from BLG-180 to the BLG-300 has worked successfully and this is anticipated to be applicable to larger RPCVD platforms.
This achievement also enabled the company to recommence collaborative efforts with Veeco Instruments and HC Semitek.
- In November, BluGlass published its best RPCVD performance data to date, presenting the new technical data at the invite-only Workshop for Ultra-Precision Processing for Wide Band-Gap Semiconductors (WUPP) in the USA. BluGlass was invited to present at the 5th International WUPP workshop, which gathers many of the leading groups and companies in the nitrides community to discuss various topics ranging from LEDs, Laser Diodes and power electronics. In the data BluGlass presented greater than 30% performance improvement in RPCVD p-GaN based green LEDs compared to BluGlass’ MOCVD green LEDs measured at the wafer level.
BluGlass Limited
Page 4 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
- Also in November, BluGlass launched our custom epitaxial brand, EpiBlu Pty Ltd. The service business continues to provide a growing source of revenue for BluGlass, as well as a pipeline of future collaborators and customers. EpiBlu’s service business is ultimately a valuable part of the commercialisation strategy of the RPCVD technology into a broad range of applications. We will continue to establish the EpiBlu brand and expand the business based on our growing reputation and positive results from existing customers. BluGlass and EpiBlu will be featured at a number of key industry events as speakers, exhibitors and sponsors over the coming year.
Partnerships Update
Lumileds Phase II of Exclusive Collaboration
BluGlass is working with leading US based LED company Lumileds, on a novel application of LEDs that capitalises on the unique low temperature advantages of RPCVD.
Much of BluGlass’ effort during the half year was spent advancing the second phase of the exclusive collaboration with Lumileds, which is continuing to make good progress and further advance the capabilities and performance of our RPCVD technology.
Development has been slower than anticipated with the decommissioning of the old BLG-300 chamber at the start of the half year to install and commission the upgraded chamber and also by the extended turnaround timeframes of iterations between BluGlass and Lumileds in the US.
The new BLG-300 chamber is now positively contributing to this ongoing project. Both companies are also actively looking at ways to accelerate the turnaround time between development cycles.
==> picture [484 x 321] intentionally omitted <==
BluGlass Limited
Page 5 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
IQE Collaboration for Electronics Applications
During the half year BluGlass has been collaborating with IQE, one of the world’s leading semiconductor foundries and a global leader in the design and manufacture of advanced semiconductor wafer products. BluGlass and IQE are collaborating to develop a specific enabling technology for high quality nitride films deposited by RPCVD on both silicon wafers and on specially engineered substrates; cREO™ on silicon wafers.
This collaboration is ongoing and both companies remain committed to achieving the technology goals. Based on the previous work we completed with the cREO technology, we have been able to make quick initial gains in this project. As per the Lumileds collaboration, the IQE project is also being assisted with the new BLG-300 chamber.
Veeco Collaboration
Following the installation and commissioning of the upgraded BLG-300, BluGlass recommenced its evaluation with leading semiconductor equipment manufacturer Veeco Instruments.
At the Company’s AGM in November, Veeco allowed us to share some of the p-GaN performance data for power electronics, which demonstrates the possibility of a lower temperature deposition technology to improve the performance of Off HEMTs for power electronics.
BluGlass and Veeco are actively exploring additional collaboration opportunities during 2018, capitalising on recent advancements with the RPCVD technology and scaling.
Performance Data Update
Since the company’s AGM in November 2017, BluGlass has demonstrated a large improvement in RPCVD blue LED light output. In recent months BluGlass has placed initial development effort on the demonstration of RPCVD grown multi-quantum wells (MQW’s), the active, light emitting layers of an LED and the most complex growth demonstration in the LED structure. MQW’s are a key opportunity for performance improvement with lower temperature growth.
Our initial demonstrations are showing strong promise, and while not yet on par with MOCVD benchmarks (still early stage development), the RPCVD MQW performance is quickly improving as we continue to focus efforts on this aspect of the technology to help enable high performance RGB LEDs and microLEDs.
RPCVD MQW BASED LEDs November 2017
RPCVD MQW BASED LEDs February 2018
==> picture [181 x 176] intentionally omitted <==
----- Start of picture text -----
At 100 mA
V = 4.4 V
f
λ = 451 nm
FW = 31 nm
LOP = 0.6 mW
----- End of picture text -----
==> picture [180 x 175] intentionally omitted <==
----- Start of picture text -----
At 100 mA
V = 5.9 V
f
λ = 459 nm
FW = 24 nm
LOP = 2.4 mW
----- End of picture text -----
BluGlass has demonstrated a four fold improvement in RPCVD MQW’s blue LED light output (LOP) since last the update in November 2017.
BluGlass Limited
Page 6 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
The Half Year Ahead:
As we head into the remaining half of the 2018 financial year, BluGlass will continue to deliver progress towards successful outcomes in our current industry partnerships. These discussions and collaborations are in different stages of development, but each one of them has significant market potential once fully realised .
Following the recent launch of our service brand, EpiBlu, we plan to grow this business during the remaining half year; while also working with potential future collaborators and customers of the RPCVD technology. To support this goal, we will develop a market presence at several international semiconductor conferences during the year as sponsors, speakers and exhibitors.
BluGlass will also continue to actively pursue new applications for its RPCVD technology such as micro-LEDs whereby the low temperature deposition process might lead to device performance improvements.
For the remaining half year BluGlass’ goals remain unchanged. We are focused on the successful demonstration of the competitive advantages of our technology with our industry partners to ultimately enter commercial negotiations with one or more of our partners.
==> picture [264 x 312] intentionally omitted <==
The BluGlass Board and Management look forward to delivering commercial outcomes for our shareholders and our breakthrough technology in the year ahead.
Director William Johnson
Director Giles Bourne
==> picture [112 x 42] intentionally omitted <==
==> picture [146 x 49] intentionally omitted <==
Dated this 13[th] day of February 2018
BluGlass Limited
Page 7 of 17
Half Yearly Results 31 December 2017
==> picture [467 x 65] intentionally omitted <==
Level 17, 383 Kent Street Sydney NSW 2000
Correspondence to: Locked Bag Q800 QVB Post Office Sydney NSW 1230
T +61 2 8297 2400 F +61 2 9299 4445 E [email protected] W www.grantthornton.com.au
Auditor’s Independence Declaration to the Directors of BluGlass Limited
In accordance with the requirements of section 307C of the Corporations Act 2001 , as lead auditor for the review of BluGlass Limited for the half-year ended 31 December 2017. I declare that, to the best of my knowledge and belief, there have been:
-
a No contraventions of the auditor independence requirements of the Corporations Act 2001 relation to the review; and
-
b No contraventions of any applicable code of professional conduct in relation to the review.
==> picture [155 x 32] intentionally omitted <==
Grant Thornton Audit Pty Ltd Chartered Accountants
==> picture [94 x 63] intentionally omitted <==
P J Woodley Partner – Audit & Assurance
Sydney, 13 February 2018
Grant Thornton Audit Pty Ltd ACN 130 913 594 a subsidiary or related entity of Grant Thornton Australia Ltd ABN 41 127 556 389
‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to Grant Thornton Australia Limited.
Liability limited by a scheme approved under Professional Standards Legislation.
Page 8 of 17
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE HALF YEAR ENDED 31 DECEMBER 2017
| Note Revenue Other Income Employee benefits expense Professional fees Board and secretarial fees Corporate compliance & legal expenses Consultant fees Rent expense Travel and accommodation expense Engineering, consumable & repairs expense Depreciation expense Share based payment expense Other expenses Loss before income tax Income tax expense Loss for the period Other comprehensive income Total comprehensive loss attributable to members of the parent entity Loss attributable to: --members of the parent entity Total Comprehensive loss attributable --members of the parent entity Earnings/(loss) per share Basic earnings/(loss) per share (cents per share) Diluted earnings/(loss) per share (cents per share) |
Consolidated Group 31.12.2017 31.12.2016 $ $ 351,814 243,584 940,096 1,016,995 (1,314,668) (1,352,667) (110,999) (115,245) (137,457) (145,006) (139,179) (60,827) (103,251) (180,367) (139,263) (133,486) (90,103) (42,961) (648,614) (498,292) (101,918) (253,319) (168,409) (264,193) (297,584) (276,644) |
|---|---|
| (1,959,535) (2,062,428) - - |
|
| (1,959,535) (2,062,428) |
|
| - - |
|
| (1,959,535) (2,062,428) |
|
| (1,959,535) (2,062,428) |
|
| (1,959,535) (2,062,428) |
|
| (1,959,535) (2,062,428) |
|
| (1,959,535) (2,062,428) |
|
| (0.51) (0.57) (0.51) (0.57) |
These financial statements should be read in conjunction with the accompanying notes.
BluGlass Limited
Page 9 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2017
| ASSETS Current Assets Cash and cash equivalents Trade and other receivables Consumables Other current assets TOTAL CURRENT ASSETS Non-Current Assets Property, plant and equipment Intangible assets TOTAL NON-CURRENT ASSETS TOTAL ASSETS LIABILITIES Current Liabilities Trade and other payables Short-term provisions TOTAL CURRENT LIABILITIES Non-current Liabilities Long-term provisions TOTAL NON-CURRENT LIABILITIES TOTAL LIABILITIES NET ASSETS EQUITY Issued capital Reserves Accumulated Losses TOTAL EQUITY |
Consolidated Group 31.12.2017 30.06.2017 $ $ 7,755,012 8,510,931 1,000,000 2,163,719 91,164 103,843 118,479 43,205 |
|---|---|
| 8,964,655 10,821,698 |
|
| 265,130 336,200 8,695,000 8,695,000 |
|
| 8,960,130 9,031,200 |
|
| 17,924,785 19,852,898 |
|
| 178.480 398,632 421,696 400,865 |
|
| 600,176 799,497 |
|
| 358,824 351,590 |
|
| 358,824 351,590 |
|
| 959,000 1,151,087 |
|
| 16,965,785 18,701,811 |
|
| 56,964,707 56,630,407 (541,452) 175,181 (39,457,470) (38,103,777) |
|
| 16,965,785 18,701,811 |
These financial statements should be read in conjunction with the accompanying notes.
BluGlass Limited
Page 10 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE HALF YEAR ENDED 31 DECEMBER 2017
| Balance at 1 July 2016 Total comprehensive loss for the period Transactions with owners in their capacity as owners: Share options issued Share Transaction costs during this year Share options issued Exercise of share options Dividends paid or provided for Balance at 31 December 2016 Balance at 1 July 2017 Total comprehensive loss for the period Transactions with owners in their capacity as owners: Shares issued during the year Share options issued Exercise of share options Transfer to reserve Dividends paid or provided for Balance at 31 December 2017 |
Issued Capital Share based payments Reserve Other Reserve $ $ $ |
Accumulated Losses Total $ $ |
|---|---|---|
| 48,575,895 1,086,527 (982,452) (34,443,220) 14,236,750 - - - (2,062,428) (2,062,428) 8,126,000 - - - 8,126,000 (426,117) - - - (426,117) - 274,405 - - 274,405 541,416 512,996 28,420 - - - - - |
||
| 56,817,194 847,936 (982,452) (36,505,653) 20,177,030 |
||
| 56,630,507 1,157,633 (982,452) (38,103,777) 18,701,911 - - - (1,959,535) (1,959,535) - - - - - - 168,409 - - 168,409 334,200 (279,200) - - 55,000 - - (605,842) - 605,842 - - - - - - |
||
| 56,964,707 441,000 (982,452) (39,457,470) 16,965,785 |
BluGlass Limited
Page 11 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE HALF YEAR ENDED 31 DECEMBER 2017
| CASH FLOWS FROM OPERATING ACTIVITIES Interest & other income received Payments to suppliers and employees Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property, plant and equipment Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issue of shares net of transaction costs Proceeds from options exercised Net cash provided by financing activities Net (decrease)/increase in cash held Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period |
Consolidated Group 31.12.2017 31.12.2016 $ $ 1,291,910 1,260,579 (2,073,832) (1,833,953) |
|---|---|
| (781,922) (573,374) |
|
| (30,847) (8,726) |
|
| (30,847) (8,726) |
|
| - 7,718,595 56,850 - |
|
| 7,718,595 7,718,595 |
|
| (755,919) 7,136,495 8,510,931 3,409,700 |
|
| 7,755,012 10,546,195 |
These financial statements should be read in conjunction with the accompanying notes.
BluGlass Limited
Page 12 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
NOTES TO THE FINANCIAL STATEMENTS FOR THE HALF YEAR ENDED 31 DECEMBER 2017
Note 1: Nature of Operation
The principal activity of the consolidated entity during the half year was the further development and commercialisation of novel technology for the manufacture of epitaxially grown gallium nitride at low temperature. BluGlass is also engaged in research activities in developing a high efficiency nitride solar cell prototype.
Note 2: Basis of Preparation
These general purpose financial statements for the half-year reporting period ended 31 December 2017 have been prepared in accordance with requirements of the Corporations Act 2001 and AASB 134: Interim Financial Reporting. Compliance with AASB 134 ensures compliance with International Financial reporting standard IAS34 Interim Financial Reporting. The group is a for profit entity for financial reporting purposes under Australian Accounting standards.
This interim financial report is intended to provide users with an update on the latest annual financial statements of BluGlass Limited and its controlled entities (the Group). As such, it does not contain information that represents relatively insignificant changes occurring during the half year within the Group. It is therefore recommended that this financial report be read in conjunction with the annual financial report of the Group for the year ended 30 June 2017, together with any public announcements made during the half-year.
The same accounting policies and methods of computation have been followed in this interim financial report as were applied in the most recent annual financial statements, except in relation to the matters discussed below.
Significant Accounting Policies
The interim financial statements have been prepared in accordance with the accounting policies adopted in the Group’s last annual financial statements for the year ended 30 June 2017.
The financial statements of BluGlass Limited for the half year ended 31 December 2017 were authorised for issue in accordance with a resolution of the directors on 13 February 2017.
Going Concern
Notwithstanding the accumulated losses for the company and the consolidated entity, the directors have performed a review of the cash flow forecasts and have considered the cash flow needs of the company and consolidated entity. The directors have prepared the financial statements on a going concern basis, as the directors have a number of strategies in progress to generate revenues from operations and maintain the company in a cashflow positive position.
Note 3: Loss for the Period
| The following revenue and expense items are relevant in explaining the financial performance for the interim period: Foundry Revenue R&D Tax rebate Interest Income |
Consolidated Group 31.12.2017 31.12.2016 268,149 203,468 1,000,000 1,000,000 23,761 57,111 |
|---|---|
| 1,291,910 1,260,579 |
Note 4: Dividends
There were no dividends paid or declared during the period.
BluGlass Limited
Page 13 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
NOTES TO THE FINANCIAL STATEMENTS FOR THE HALF YEAR ENDED 31 DECEMBER 2017
Note 5: Operating Segments
The consolidated group operates and reports in one business and geographic segment.
Note 6: Losses Per Share
Both the basic and diluted losses per share have been calculated using the losses attributable to shareholders of the Parent Company (BluGlass Limited) as the numerator, i.e. no adjustments to losses were necessary during the six (6) month period to 31 December 2017 and 2016.
The weighted average number of shares for the purposes of the calculation of diluted losses per share can be reconciled to the weighted average number of ordinary shares used in the calculation of basic losses per share as follows:
| 6 months to 31-Dec-2017 |
6 months to 31-Dec-2016 |
|
|---|---|---|
| Weighted average number of shares used in basic earnings per share | 384,054,162 | 362,389,557 |
| Weighted average number of shares used in diluted earnings per share | 384,054,162 | 362,389,557 |
Note 7: Share Capital
| 6 months to 31 December 2017 |
Year to 30 June 2017 |
|
|---|---|---|
| Shares issued and fully paid | ||
| Beginningof theperiod | 382,461,266 | 354,225,508 |
| Issued under share-basedpaymentplans | 5,500,000 | 2,842,000 |
| Shares issued | - | 25,393,758 |
| Shares issued and fully paid | 387,961,266 | 382,461,266 |
| Shares authorised for share basedpayments | 5,270,000 | 8,770,000 |
| Total shares authorised at the end of theperiod | 393,231,266 | 391,231,266 |
Note 8: Contingent liabilities
There has been no change in contingent liabilities since the last annual reporting date.
Note 9: Events subsequent to reporting date
There were no events subsequent to reporting date.
BluGlass Limited
Page 14 of 17
Half Yearly Results 31 December 2017
BLUGLASS LIMITED and Controlled Entities ABN 20 116 825 793
DIRECTORS’ DECLARATION
The directors of the company declare that:
-
the financial statements and notes as set out on pages 9 to 14 are in accordance with the Corporations Act 2001 and:
-
(a) comply with Accounting Standards AASB 134 Interim Financial Reporting; and
-
(b) give a true and fair view of the financial position as at 31 December 2017 and of the performance for the half year ended on that date.
-
in the directors’ opinion, there are reasonable grounds to believe that the group will be able to pay its debts as and when they become due and payable.
This declaration is made in accordance with a resolution of the Board of Directors.
==> picture [112 x 42] intentionally omitted <==
==> picture [146 x 49] intentionally omitted <==
Director William Johnson Managing Director Giles Bourne
Dated this 13[th] day of February 2018
BluGlass Limited
Page 15 of 17
Half Yearly Results 31 December 2017
==> picture [466 x 65] intentionally omitted <==
Level 17, 383 Kent Street Sydney NSW 2000
Correspondence to: Locked Bag Q800 QVB Post Office Sydney NSW 1230
T +61 2 8297 2400 F +61 2 9299 4445 E [email protected] W www.grantthornton.com.au
Independent Auditor’s Review Report To the Members of BluGlass Limited
Report on the Half Year Financial Report
Conclusion
We have reviewed the accompanying half year financial report of Bluglass Limited (the Company) and its subsidiaries (the Group), which comprises the consolidated statement of financial position as at 31 December 2017, and the consolidated statement of profit or loss and other comprehensive income, consolidated statement of changes in equity and consolidated statement of cash flows for the half year ended on that date, a description of accounting policies, other selected explanatory notes, and the directors’ declaration.
Based on our review, which is not an audit, nothing has come to our attention that causes us to believe that the half year financial report of BluGlass Limited does not give a true and fair view of the financial position of the Group as at 31 December 2017, and of its financial performance and its cash flows for the half year ended on that date, in accordance with the Corporations Act 2001, including complying with Accounting Standard AASB 134 Interim Financial reporting.
Directors Responsibility for the Half Year Financial Report
The Directors of the Group are responsible for the preparation of the half-year financial report that gives a true and fair view in accordance with Australian Accounting Standards and the Corporations Act 2001 and for such internal control as the directors determine is necessary to enable the preparation of the half-year financial report that gives a true and fair view and is free from material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express a conclusion on the half year financial report based on our review. We conducted our review in accordance with Auditing Standard on Review Engagements ASRE 2410 Review of a Financial Report Performed by the Independent Auditor of the Entity, in
Grant Thornton Audit Pty Ltd ACN 130 913 594
a subsidiary or related entity of Grant Thornton Australia Ltd ABN 41 127 556 389
‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or refers to one or more member firms, as the context requires. Grant Thornton Australia Ltd is a member firm of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one another and are not liable for one another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to Grant Thornton Australia Limited ABN 41 127 556 389 and its Australian subsidiaries and related entities. GTIL is not an Australian related entity to Grant Thornton Australia Limited.
Liability limited by a scheme approved under Professional Standards Legislation.
Page 16 of 17
==> picture [326 x 46] intentionally omitted <==
order to state whether, on the basis of the procedures described, we have become aware of any matter that makes us believe that the half year financial report is not in accordance with the Corporations Act 2001 including giving a true and fair view of the Group’s financial position as at 31 December 2017 and its performance for the half year ended on that date, and complying with Accounting Standard AASB 134 Interim Financial Reporting and the Corporations Regulations 2001. As the auditor of BluGlass Limited, ASRE 2410 requires that we comply with the ethical requirements relevant to the audit of the annual financial report.
A review of a half year financial report consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Australian Auditing Standards and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Independence
In conducting our review, we have complied with the independence requirements of the Corporations Act 2001.
==> picture [155 x 32] intentionally omitted <==
Grant Thornton Audit Pty Ltd Chartered Accountants
P J Woodley Partner - Audit & Assurance
Sydney, 13 February 2018
Page 17 of 17